Re-Vana Therapeutics Company
Re-Vana is developing sustained release ocular biologics. In addition, we can reduce the need for topical drug delivery.
Investors
%20.jpg)
%20.jpg)
Founded Date:
2015
Total Funding:
$109.9M
Employee Number:
1-10
Funding Status:
Seed
Technology:
Anti-infective Drugs
Last Funding Type:
Series B
Investors Number:
3
Industry:
PharmTech
Headquarters:
Belfast, Belfast, United Kingdom
Estimated Revenue:
Less than $1M